Examines prescribing trends among the top 200 drugs, covering chronic disease medications, usage shifts, cost factors, disparities, and industry influences.
Breaks down BPES syndrome, exploring eyelid features, Type I and II differences, the role of the FOXL2 gene, inheritance patterns, and surgical options.